Skip to main content
HCAT
NASDAQ Technology

Institutional Investor Whetstone Capital Reduces Stake in Health Catalyst

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.724
Mkt Cap
$128.945M
52W Low
$0.955
52W High
$4.291
52W Position info
81% above low
Off High info
60% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

HCAT sits 81% above its 52-week low of $0.955 on elevated volume (2.1× avg).

Summary

Institutional investor Whetstone Capital Advisors sold over $4.7 million in Health Catalyst stock, reducing its stake to 4.5% following the company's recent divestiture announcement.


Key Events · Ownership and Investor Activity · HCAT

  • Significant Stock Sales

    Whetstone Capital Advisors sold 2,524,251 shares of common stock on June 4-5, 2026, for a total value of approximately $4.72 million.

  • Reduced Ownership Stake

    The sales reduced Whetstone Capital Advisors' beneficial ownership to 3,285,690 shares, representing 4.5% of Health Catalyst's common stock.

  • Post-Divestiture Selling

    These sales occurred immediately after Health Catalyst announced the divestiture of its Vitalware business unit for $147 million in cash on June 4, 2026.


Analysis · HCAT · Technology

Whetstone Capital Advisors, an institutional investor, significantly reduced its stake in Health Catalyst by selling over $4.7 million worth of common stock. This divestment, occurring immediately after the company announced a $147 million business unit divestiture, suggests a lack of confidence despite recent efforts to improve the balance sheet. The reduction to 4.5% ownership marks a notable decrease in their position.

How filings like this one have moved

In the 30 days to Sep 12, 2026, 29.8% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCAT was trading at $1.72 on NASDAQ in the Technology sector, with a market capitalization of approximately $128.9M. The 52-week trading range was $0.96 to $4.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCAT - Latest Insights

HCAT
Sep 08, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.70 info
Change: $0 (0%) info
Market Cap: $127.936M info
HCAT
Sep 08, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.70 info
Change: +$0.070 (+4%) info
Market Cap: $127.936M info
HCAT
Aug 06, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.70 info
Change: +$0.030 (+2%) info
Market Cap: $127.936M info
HCAT
Aug 06, 2026, 4:03 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.86
Real-time Price: $1.70 info
Change: -$0.160 (-9%) info
Market Cap: $127.936M info
HCAT
Jul 17, 2026, 6:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $1.70 info
Change: -$0.500 (-23%) info
Market Cap: $127.936M info